Literature DB >> 21923655

Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting.

Brian L McClune, Todd Defor, Claudio Brunstein, Rachel I Vogel, Navneet S Majhail, Veronika Bachanova, Linda J Burns, Arne Slungaard, Daniel J Weisdorf.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21923655      PMCID： PMC4582652          DOI： 10.1111/j.1365-2141.2011.08842.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

2.  Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia.

Authors:  M J Keating; S O'Brien; D Kontoyiannis; W Plunkett; C Koller; M Beran; S Lerner; H Kantarjian
Journal:  Leuk Lymphoma       Date:  2002-09

3.  Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis.

Authors:  P Dreger; R Brand; D Milligan; P Corradini; J Finke; G Lambertenghi Deliliers; R Martino; N Russell; A van Biezen; M Michallet; D Niederwieser
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

Review 4.  Expanding the role of umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Daniela C Setubal; John E Wagner
Journal:  Br J Haematol       Date:  2007-04       Impact factor: 6.998

5.  Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study.

Authors:  Julio Delgado; Kirsty Thomson; Nigel Russell; Joanne Ewing; Wendy Stewart; Gordon Cook; Stephen Devereux; Richard Lovell; Rajesh Chopra; David I Marks; Stephen Mackinnon; Donald W Milligan
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

6.  Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

Authors:  J Schetelig; C Thiede; M Bornhauser; R Schwerdtfeger; M Kiehl; J Beyer; H G Sayer; N Kroger; M Hensel; C Scheffold; T K Held; K Hoffken; A D Ho; J Kienast; A Neubauer; A R Zander; A A Fauser; G Ehninger; W Siegert
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

7.  Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

Authors:  Navneet S Majhail; Claudio G Brunstein; Marcie Tomblyn; Avis J Thomas; Jeffrey S Miller; Mukta Arora; Dan S Kaufman; Linda J Burns; Arne Slungaard; Philip B McGlave; John E Wagner; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2008-03       Impact factor: 5.742

8.  Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Authors:  Mohamed L Sorror; Barry E Storer; Brenda M Sandmaier; Michael Maris; Judith Shizuru; Richard Maziarz; Edward Agura; Thomas R Chauncey; Michael A Pulsipher; Peter A McSweeney; James C Wade; Benedetto Bruno; Amelia Langston; Jerald Radich; Dietger Niederwieser; Karl G Blume; Rainer Storb; David G Maloney
Journal:  J Clin Oncol       Date:  2008-09-15       Impact factor: 44.544

9.  Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.

Authors:  Celso A Rodrigues; Guillermo Sanz; Claudio G Brunstein; Jaime Sanz; John E Wagner; Marc Renaud; Marcos de Lima; Mitchell S Cairo; Sabine Fürst; Bernard Rio; Christopher Dalley; Enric Carreras; Jean-Luc Harousseau; Mohamad Mohty; Denis Taveira; Peter Dreger; Anna Sureda; Eliane Gluckman; Vanderson Rocha
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

10.  Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Susana Cantero; Qing Cao; Navneet Majhail; Brian McClune; Linda J Burns; Marcie Tomblyn; Jeffrey S Miller; Bruce R Blazar; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2009-02       Impact factor: 5.742
  10 in total
  2 in total

Review 1.  Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.

Authors:  Douglas E Gladstone; Ephraim Fuchs
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

2.  Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.

Authors:  William K Decker; Nina Shah; Dongxia Xing; Ruth Lapushin; Sufang Li; Simon N Robinson; Hong Yang; Simrit Parmar; Matthew M Halpert; Michael J Keating; John G Gribben; Jeffrey J Molldrem; Elizabeth J Shpall; William G Wierda
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.